The Vaccine Economics Research for Sustainability and Equity (VERSE) project evaluated the status of vaccine coverage and equity status in South Africa in 2016.
-
VERSE Equity Reports
-
Methods
This document outlines the methods used in the VIEW-hub data collection and data update process.
-
VIEW-Hub Reports
The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the
-
VERSE Equity Reports
The Vaccine Economics Research for Sustainability and Equity (VERSE) project evaluated the status of vaccine coverage and equity status in Afghanistan in 2015.
-
VERSE Equity Reports
The Vaccine Economics Research for Sustainability and Equity (VERSE) project evaluated the status of vaccine coverage and equity status in Uganda in 2016.
-
Methods
This document outlines the methods used in the COVID-19 vaccine safety survey presented in the VIEW-hub COVID safety studies module.
-
Results & Summaries
This document summarizes COVID-19 vaccine safety published studies and survey results in map form. Full results can be found on the VIEW-hub COVID safety module.
-
VIEW-Hub Reports
The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the
-
Methods
This document outlines the methods used in the COVID-19 vaccine safety literature review presented in the VIEW-hub COVID safety studies module.
-
Briefs
In partnership with the Asian Development Bank, IVAC summarized the evidence for COVID-19 vaccine performance against Omicron sub-variants.